Cell Therapy Manufacturing Market Research Report 2019-2030

By Author: Stella Wilson
Total Articles: 45
Comment this article

Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry

The USD 11 billion (by 2030) financial opportunity within the Cell Therapy Manufacturing Market has been analyzed across the following segments:

Market Key Players:
Type of therapy
• T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)
• Dendritic cell therapies
• Tumor cell therapies
• NK cell therapies
• Stem cell therapies

Source of cells
• Autologous
• Allogeneic

Scale of operation
• Clinical
• Commercial

Purpose of manufacturing
• Contract manufacturing
• In-house manufacturing

Key geographical regions
• North America
• Europe
• Asia Pacific
• Rest of the world

Read ...
... Detailed Analysis: https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

The Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030 report features the following companies, which we identified to be key players in this domain:

Market Key Players:
• BioNTech Innovative Manufacturing Services
• Cell Therapies
• Cell and Gene Therapy Catapult
• Center for Cell and Gene Therapy, Baylor College of Medicine
• Centre for Cell Manufacturing Ireland, National University of Ireland
• Clinical Cell and Vaccine Production Facility, University of Pennsylvania
• Cognate BioServices
• FUJIFILM
• Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital
• Hitachi Chemical
• KBI Biopharma
• Laboratory for Cell and Gene Medicine, Stanford University
• Lonza
• MaSTherCell
• MEDINET
• Molecular and Cellular Therapeutics, University of Minnesota
• Newcastle Cellular Therapies Facility, Newcastle University
• Nikon CeLL innovation
• Rayne Cell Therapy Suite, King’s College London
• Roslin Cell Therapies
• Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine
• Sydney Cell and Gene Therapy
• WuXi Advanced Therapies

Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Overview
5. Regulatory Landscape
6. Roadmaps for Overcoming Existing Challenges
7. Automation Technologies for Cell Therapy Manufacturing
8. Profiles: Industry Players
9. Profiles: Non-Industry Players
10. Role of Non-Profit Organizations
11. Partnerships
12. Facility Expansions
13. Capacity Analysis
14. Demand Analysis
15. Cost Price Analysis
16. Make Versus Buy Decision Making Framework
17. Market Sizing and Opportunity Analysis
18. Key Insights
19. SWOT Analysis
20. Conclusion
21. Survey Analysis
22. Interview Transcripts
23. Appendix 1: Tabulated Data
24. Appendix 2: List of Companies and Organizations

For more information, please click on the following link:
https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Contact Information
Roots Analysis Private Limited
Gaurav Chaudhary
+1 (415) 800 3415
Gaurav.Chaudhary@rootsanalysis.com